"10.1371_journal.pone.0082796","plos one","2013-12-10T00:00:00Z","Carmen Tur; Mar Tintoré; Ángela Vidal-Jordana; Denis Bichuetti; Pablo Nieto González; María Jesús Arévalo; Georgina Arrambide; Elisenda Anglada; Ingrid Galán; Joaquín Castilló; Carlos Nos; Jordi Río; María Isabel Martín; Manuel Comabella; Jaume Sastre-Garriga; Xavier Montalban","Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology-Neuroimmunology, Vall d’Hebron University Hospital, Barcelona, Spain; Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil; Department of Neurology, University Hospital Príncipe de Asturias, Alcalá de Henares, Madrid, Spain","Conceived and designed the experiments: CT MT DB. Performed the experiments: CT PNG. Analyzed the data: CT. Contributed reagents/materials/analysis tools: CT AVJ MJA JC EA MIM. Wrote the manuscript: CT. Revision of manuscript: MT AVJ DB PNG MJA GA EA IG JC CN JR MIM MC JSG XM.","CT has received honoraria and support for travel from Merk-Serono, Sanofi-Aventis, Teva, and Novartis.  MT has received compensation for consulting services and speaking from Bayer-Schering, Merck-Serono, Biogen-Idec, Teva, Sanofi-Aventis, and Novartis.  DB has received speaking/consulting honoraria from Bayer Health Care, Biogen Idec, Merck Serono, Sanofi and TEVA and had travel expenses to scientific meetings sponsored by Bayer Health Care, Merck Serono and TEVA.  MJA has received speaking honoraria from Bayer Schering Pharma, Merck Serono and Teva Pharmaceutical Industries.  IG has received compensation for speaking from Teva.  CN has received lecture fees from Merck-Serono and honoraria for giving expert advice to Lilly and BaroFold.  JR has received compensation for consulting services and speaking from Bayer-Schering, Merck-Serono, Biogen- Idec, and Novartis. MC has received compensation for speaking from Teva.  JSG has received compensation for consulting services and speaking from Biogen, Merck-Serono, Novartis, Teva, Sanofi-Aventis, Almirall and Bayer.  XM has received speaking honoraria and travel expenses for scientific meetings, has been a steering committee member of clinical trials or participated in advisory boards of clinical trials in the past years with Bayer Schering Pharma, Biogen Idec, EMD Merck Serono, Genentech, Genzyme, Novartis, Sanofi-Aventis, Teva Pharmaceuticals and Almirall.  This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Carmen Tur","CT",16,TRUE,3,2,1,1,TRUE,TRUE,TRUE,1,"3",FALSE
